CLINICAL TRIALS PROFILE FOR FERRIC CARBOXYMALTOSE
✉ Email this page to a colleague
All Clinical Trials for ferric carboxymaltose
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00548691 ↗ | Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients | Completed | American Regent, Inc. | Phase 3 | 2007-10-01 | The Objective of this study is to study the safety of FCM in patients with anemia caused by chronic kidney failure |
NCT00548691 ↗ | Safety and Tolerability of FCM vs Standard of Care in Treating Iron Deficiency Anemia in Chronic Kidney Disease Patients | Completed | Luitpold Pharmaceuticals | Phase 3 | 2007-10-01 | The Objective of this study is to study the safety of FCM in patients with anemia caused by chronic kidney failure |
NCT00548860 ↗ | Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients | Completed | American Regent, Inc. | Phase 3 | 2007-10-01 | The Objective of this study is to study the safety of FCM in patients with anemia caused by Heavy Uterine Bleeding and the Post Partum state. |
NCT00548860 ↗ | Safety of FCM vs. Standard of Care in Treating Iron Deficiency Anemia in Heavy Uterine Bleeding and Post Partum Patients | Completed | Luitpold Pharmaceuticals | Phase 3 | 2007-10-01 | The Objective of this study is to study the safety of FCM in patients with anemia caused by Heavy Uterine Bleeding and the Post Partum state. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for ferric carboxymaltose
Condition Name
Clinical Trial Locations for ferric carboxymaltose
Trials by Country
Clinical Trial Progress for ferric carboxymaltose
Clinical Trial Phase
Clinical Trial Sponsors for ferric carboxymaltose
Sponsor Name